Click here - to use the wp menu builder

Cerevel Therapeutics Expands Executive Team with Three Appointments to Accelerate Next Phase of Growth and Pipeline Advancement

May 28, 2019

BOSTON–(BUSINESS WIRE)–Cerevel Therapeutics expands executive team with three appointments to accelerate next phase of growth and pipeline advancement.

http://www.businesswire.com/news/home/20190528005178/en/Cerevel-Therapeutics-Expands-Executive-Team-Appointments-Accelerate

Cerevel Therapeutics Expands Executive Team with Three Appointments to Accelerate Next Phase of Growth and Pipeline Advancement

Recent Articles

Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India

Target RWE Acquires NoviSci Inc., Adding Significant Analytical Capabilities to Leading Real-World Evidence Platform

VBI Vaccines Announces Publication of Results from a Phase 4 Study of VBI’s Prophylactic 3-Antigen Hepatitis B Vaccine in Vaccine

Navitus Health Solutions Launches Program to Help Members Overcome Challenges Along the Prescription Journey

Arcus Biosciences Presents Promising Initial Data from Phase 1 Portion of ARC-8 Study for AB680 in Metastatic Pancreatic Cancer